Genentech at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Genentech brings 1 presentation to ObesityWeek 2026 in National Harbor, and exhibits at Booth 330, Suite 26. Its program covers petrelintide given together with enicepatide in people living with obesity or overweight, from the ZYNERGY study.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Genentech South San Francisco, CA | ◇Bronze Sponsor |
Roche Group biotechnology company that discovers, develops and markets medicines for serious diseases. | Booth Exhibiting at Booth 330, Suite 26 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm Poster Mon Nov 16 2:30pm–3:30pm Petrelintide Co-Administered With Enicepatide in People Living With Obesity or Overweight (ZYNERGY) Chronic disease and obesity complications |
Find decision makers at Genentech
Tell us what you sell and we’ll find the people at Genentech most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction